The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib - Publication - Bridge of Knowledge

Your account

login

Search

The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib

Abstract

Citations

  • 7

    CrossRef

  • 0

    Web of Science

  • 1 1

    Scopus

Authors (12)

  • Photo of Pawel Robak

    Pawel Robak

  • Photo of Dariusz Jarych

    Dariusz Jarych

  • Photo of Damian Mikulski

    Damian Mikulski

  • Photo of Izabela Dróżdż

    Izabela Dróżdż

  • Photo of Edyta Węgłowska

    Edyta Węgłowska

  • Photo of Aleksandra Kotkowska

    Aleksandra Kotkowska

  • Photo of Małgorzata Misiewicz

    Małgorzata Misiewicz

  • Photo of Piotr Smolewski

    Piotr Smolewski

  • Photo of dr n. med. Konrad Stawiski

    Konrad Stawiski dr n. med.

  • Photo of Wojciech Fendler

    Wojciech Fendler

  • Photo of Janusz Szemraj

    Janusz Szemraj

  • Photo of Tadeusz Robak

    Tadeusz Robak

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
Cancers no. 13, edition 5,
ISSN: 2072-6694
ISSN:
2072-6694
Publication year:
2021
DOI:
Digital Object Identifier (open in new tab) 10.3390/cancers13050951
Verified by:
No verification

seen 98 times

Meta Tags